Modulation of survivin expression
Details for Australian Patent Application No. 2010202724 (hide)
International Classifications
Event Publications
15 July 2010 Application Open to Public Inspection
Published as AU-B-2010202724
15 July 2010 Complete Application Filed
3 February 2011 Assignment before Grant
Isis Pharmaceuticals, Inc.; Eli Lilly and Company The application has been assigned to Isis Pharmaceuticals, Inc.
5 April 2012 Application Accepted
Published as AU-B-2010202724
2 August 2012 Standard Patent Sealed
Legal
The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.
Next and Previous Patents/Applications
IP Reporting Samples
Customised IP Reporting
IP Insider for IP Professionals
IP Monitor Professional
![](/images/main/3dbox_small.png)
- Editable Word format reports
- For IP Professionals
- Multiuser